|NAV: 23 May 2022||₹291.01|
|Min. SIP amount||₹100|
|Rank with in category||7||3||1||NA|
|Sun Pharmaceutical Industries Ltd.||Healthcare||Equity||13.5%|
|Divi's Laboratories Ltd.||Healthcare||Equity||7.6%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||7.5%|
|Narayana Hrudayalaya Ltd.||Healthcare||Equity||6.6%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||6.0%|
|Abbott India Ltd.||Healthcare||Equity||5.1%|
|Aurobindo Pharma Ltd.||Healthcare||Equity||4.7%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||4.6%|
Inclusive of GST
Exit load of 1% if redeemed within 1 month.
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
|Min. for 1st investment||₹5,000|
|Min. for 2nd investment onwards||₹1,000|
|Min. for SIP||₹100|
You can easily invest in Nippon India Pharma Fund Direct Growth in a hassle-free manner on Groww. The process is extremely simple, quick and completely paperless. Invest in a few minutes with the following steps:
The Nippon India Pharma Fund Direct Growth has been there from 01 Jan 2013 and the average annual returns provided by this fund is -6.64% since its inception.
Expense Ratio used for Nippon India Pharma Fund Direct Growth or any other mutual fund is the annual
charges one needs to pay to the Mutual Fund company for managing your investments in that fund.
The Expense Ratio of Nippon India Pharma Fund Direct Growth is 0.88% as of 24 May 2022...
If you want to sell your Nippon India Pharma Fund Direct Growth holdings, go to your holding on the app or web and simply click on it. You will get two options - redeem & invest more; click on redeem and enter your desired amount or if you wish to redeem the entire holding amount then select the 'redeem all' checkbox.
The NAV of Nippon India Pharma Fund Direct Growth is ₹291.01 as of 23 May 2022.